Sleep Deficiency and Cardiometabolic Disease
Epidemiologic studies have demonstrated that short sleep duration is associated with an increased risk of cardio-metabolic health outcomes including cardiovascular disease mortality, coronary heart disease, type 2 diabetes mellitus, hypertension, and metabolic syndrome. Experimental sleep restriction studies have sought to explain these findings. This review describes the main evidence of these associations and possible mechanisms explaining them. Whether sleep extension reverses these now widely acknowledged adverse health effects and the feasibility of implementing such strategies on a public health level is discussed.
Source: Clinics in Chest Medicine - Category: Respiratory Medicine Authors: Roo Killick, Lachlan Stranks, Camilla M. Hoyos Source Type: research
More News: Cardiology | Cardiovascular | Coronary Heart Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Epidemiology | Heart | Heart Disease | Hypertension | International Medicine & Public Health | Metabolic Syndrome | Respiratory Medicine | Sleep Disorders | Sleep Medicine | Study